Bass, Berry & Sims attorney Danielle Sloane provided insight for the article “Labs Face Medicare Cuts, New Codes” that was published in the online magazine Clinical OMICs on May 29. In the article, Danielle commented on the effects of the Protecting Access to Medicare Act (PAMA), which redesigns the way Medicare sets clinical laboratory reimbursement rates and requires laboratory companies to submit the reimbursement rates paid to them by commercial payors. To read the full article, click here.